Table 1.
Characteristics of relapsed patients after allogeneic HCT
| N=72 | |
|---|---|
| Median age, years (range) | 40 (4–62) |
| Gender, M/F | 42/30 |
| Histopathology | |
| Non Hodgkin lymphoma | 44 (61%) |
| B Cell Lymphoma | 31 (43%) |
| Indolent lymphomaα | 5 (7%) |
| Aggressive lymphomaß | 22 (30%) |
| Burkitt's lymphoma | 4 (6%) |
| T/NK cell lymphoma | 13 (18%) |
| Hodgkin lymphoma | 28 (39%) |
| Median number of regimens before HCT§ | 4 (1–11) |
| Chemosensitive disease at HCT | 62 (86%) |
| Previous autologous HCT | 23 (32%) |
| Conditioning regimen for allogeneic HCT | |
| Myeloablative | 17 (24%) |
| Reduced Intensity | 55 (76%) |
α
Indolent lymphoma: Chronic lymphocytic leukemia/Small lymphocytic lymphoma, marginal zone lymphoma and follicular lymphoma.
ß
Aggressive lymphoma: Mantle cell lymphoma (n=7), diffuse large B cell lymphoma (n=15).
§
HCT: Hematopoietic cell transplantation.